Expres2ion hopes for milestones after promising malaria data
The first vaccine against placental malaria might be one step closer to reality. If the development is successful, Danish Expres2ion will receive milestones and royalties for its central role in the development.
Causing 222,000 deaths every year, placental malaria pose a global health problem. But now, a prophylactic vaccine against the disease has come one step closer to realization.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
Malaria discovery can bring in millions to Expres2ion
For abonnenter
